You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
疫苗股拉昇,沃森生物(300142.SZ)一度逼近漲停
格隆匯 11-10 14:57

格隆匯11月10日丨沃森生物(300142.SZ)午後直線拉昇一度逼近漲停,帶動長春高新、復星醫藥等疫苗股集體上漲。

據悉,7月21日,沃森生物在中國臨牀試驗網登記一項mRNA疫苗ARCoVaX(ARCoV)的III期臨牀試驗,旨在評價新型冠狀病毒(mRNA)疫苗在18週歲及以上人羣中接種的保護效力、安全性和免疫原性。

科技部政務服務平台近日公示,批准多個人類遺傳資源行政許可項目信息,其中,國科遺辦審字〔2021CJ2619號旨在評價新型冠狀病毒mRNA疫苗在1859歲和60歲及以上已接種新型冠狀病毒滅活疫苗人羣中加強接種的免疫原性和安全性的IIIb期臨牀試驗。

對此,沃森生物董祕張荔表示,該事項屬於國家科技部公示信息,以科技部公佈為準。 注:國內新冠mRNA疫苗廠家有:艾博生物、沃森生物、斯微生物等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account